Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mariana Kuras

Premium

Ariana Pharma, a provider of an association rules-based clinical data analysis technology, has tapped Mariana Kuras to serve as its chief technology officer.

Prior to joining the company, Kuras worked for eight years as the director of research at Biosystems International. In this role, she was responsible for the development and validation of biomarker platform technologies focused on the application of antibodies in oncology and neurodegenerative diseases.

She has also served as a genomics and bioinformatics scientist at Pfizer Global Research and Development, and as an independent scientific expert for the sixth and seventh framework of the European Commission.

Kuras obtained a PhD in biophysics and computational biology from the University of Illinois at Urbana–Champaign.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.